Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,524,132
+$80,591 QoQ
Shares Held
16,106
+0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.61%
of 13F equity value
Holder Rank
#388
of 1,603 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empire Financial Management Company, LLC holds $13,403,297 across 5 Drug Manufacturers - General names. NVS ranks #3 (18.8% of the industry book) .
All Filings in NVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,524,132 | 16,106 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,443,541 | 15,997 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $2,272,649 | 16,484 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,095,185 | 16,338 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,928,778 | 15,939 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,749,678 | 15,695 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,486,215 | 15,273 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,653,297 | 14,374 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $1,578,588 | 14,828 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,418,158 | 14,661 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,016,364 | 10,066 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,017,072 | 9,985 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,020,401 | 10,112 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $964,620 | 10,485 | Shares | Sole | 2023-04-20 | |
| No filing history on record for this holder in this stock. | ||||||